[Gentamycin sulfate in the therapy of acute and chronic pneumonias].
Clinical efficacy of gentamicin in treatment of acute and chronic pneumonia was shown. The wide antibacterial spectrum of the antibiotic provided its use in therapy of mixed bacterial infections. Satisfactory results were observed in 47 (93.7 per cent) out of 51 patients. The adverse reactions, such as proteinuria, hematuria, and polymorphous eruption were recorded in 5 patients and vanished after discontinuation of the drug. On the basis of the experience acquired the drug may be recommended for use in pulmonology.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D005260:Female; D005839:Gentamicins / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy*; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D013997:Time Factors
D005839:Gentamicins
Gentamitsina sul'fat v terapii ostrykh i khronicheskikh pnevmoniĭ.